Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Achieves Historically Low Eight-Month Median Drug Review Time In 2017

Jan 02 2018

• By Michael Cipriano

FDA entrance sign 2016

Related Content

FDA Bests Annual Novel Drug Approval Record With Four Oks In One Week

Dec 22 2017

New Drugs And Therapeutic Biologics Approved In 2016

Jan 02 2017

Keeping Track: US FDA Approves Siliq, Accepts Mylan/Biocon Pegfilgrastim Biosimilar

Feb 18 2017

Related Companies

Lexicon Pharmaceuticals, Inc.

Genentech, Inc.

BioMarin Pharmaceutical Inc.

COSCIENS Biopharma

Takeda Pharmaceutical Co. Ltd.

Bausch Health Companies Inc.

Nicox S.A.

Additional Topics

United States Drug Review FDA Regulation BioPharmaceutical

More from Product Reviews

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window